Otovel
Product Images NDC 66992-128

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Otovel (NDC 66992-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wraser Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure-ciprofloxin (Figure 01)

Chemical Structure-ciprofloxin (Figure 01)
Chemical structure diagram of the active ingredient in OTOVEL, showing a fluorinated quinolone core with a piperazine ring and a cyclopropyl group, along with hydrochloride and water molecules indicated.*
FDA Label Image

Chemical Structure-fluocinolone Acetonide (Figure 02)

Chemical Structure-fluocinolone Acetonide (Figure 02)
Chemical structure of the active ingredient of OTOVEL, as depicted by its molecular bonds and atoms arrangement in the diagram.*
FDA Label Image

Image (Figure 03)

Image (Figure 03)
An instructional illustration showing a pair of hands being washed under running water from a faucet. The image appears to be step 1 in a sequence, indicating the start of a hand washing or hygiene procedure.*
FDA Label Image

Image (Figure 04)

Image (Figure 04)
An instructional illustration showing a close-up of a person holding and preparing to insert a swab into the ear canal. This is step 2 in a multi-step process, helping users understand the correct way to use the product OTOVEL.*
FDA Label Image

Image (Figure 05)

Image (Figure 05)
An instructional illustration showing a hand grasping the top portion of a small plastic vial, with an arrow indicating to snap off or open the vial from a connected group of three vials, likely part of a single-dose medication packaging.*
FDA Label Image

Image (Figure 06)

Image (Figure 06)
An instructional illustration showing a hand holding a small vial or ampule, preparing to open it by breaking off the top. The vial has a scored neck to facilitate opening. This image appears to be part of a step-by-step guide, labeled as step 4 in the sequence.*
FDA Label Image

Image (Figure 07)

Image (Figure 07)
An instructional illustration showing a hand breaking the neck of an OTOVEL single-dose vial to open it. The image highlights a circular arrow indicating the direction to snap the vial top for use.*
FDA Label Image

Image (Figure 08)

Image (Figure 08)
An instructional illustration showing step 6 of a process involving a person's face, with an arrow indicating an action directed toward the eye area. The grayscale image focuses on the eye region and an arrow pointing downward above it, suggesting an application or procedure step.*
FDA Label Image

Image (Figure 09)

Image (Figure 09)
An instructional illustration showing a hand administering OTOVEL ear drops into a person's ear canal, with an arrow indicating the direction of drop application. The number '7' in the corner suggests it is part of a step-by-step usage guide.*
FDA Label Image

Image (Figure 10)

Image (Figure 10)
An instructional illustration showing a hand pressing down on a circular object, demonstrating a step in using or assembling a product. The image is labeled with the number 8 in the upper left corner, indicating its sequence in a series of instructions.*
FDA Label Image

Image (Figure 11)

Image (Figure 11)
An instructional illustration showing a person lying down with their head tilted back, indicating a 1-minute duration with a clock icon near the top left corner. This image likely relates to usage or application instructions for OTOVEL by WraSer LLC.*
FDA Label Image

Principal Display Panel (0.25 mL Vial Pouch Carton)

Principal Display Panel (0.25 mL Vial Pouch Carton)
OTOVEL (ciprofloxacin 0.3% and fluocinolone acetonide 0.025%) otic solution carton for ear use. The packaging highlights it as a sterile, preservative-free product with 14 vials of 0.25 mL each. Distributed by WraSer LLC and manufactured under license by Laboratorios Salvat, S.A.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.